{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:46:31Z","timestamp":1782737191894,"version":"3.54.5"},"reference-count":53,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10750","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T07:42:12Z","timestamp":1571211732000},"source":"Crossref","is-referenced-by-count":13,"title":["The JAK inhibitor tofacitinib ameliorates immune\u2011mediated liver injury in mice"],"prefix":"10.3892","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"key20200713234149_b1-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-2007-991512","article-title":"Immune-mediated liver injury","volume":"27","author":"Eksteen","year":"2007","journal-title":"Semin Liver Dis"},{"key":"key20200713234149_b2-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"key20200713234149_b3-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"key20200713234149_b4-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis\/autoimmune sclerosing cholangitis","volume":"66","author":"Liberal","year":"2017","journal-title":"Hepatology"},{"key":"key20200713234149_b5-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3389\/fimmu.2018.01625","article-title":"Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells","volume":"9","author":"Romano","year":"2018","journal-title":"Front Immunol"},{"key":"key20200713234149_b6-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.autrev.2018.06.008","article-title":"IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases","volume":"17","author":"Beringer","year":"2018","journal-title":"Autoimmun Rev"},{"key":"key20200713234149_b7-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25\u2212 cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"key20200713234149_b8-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3748\/wjg.v20.i8.2062","article-title":"Impaired balance of T helper 17\/T regulatory cells in carbon tetrachloride-induced liver fibrosis in mice","volume":"20","author":"Sun","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20200713234149_b9-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"key20200713234149_b10-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"key20200713234149_b11-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1074\/jbc.M114.635763","article-title":"Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice","volume":"290","author":"Ji","year":"2015","journal-title":"J Biol Chem"},{"key":"key20200713234149_b12-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"key":"key20200713234149_b13-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3389\/fphar.2017.00986","article-title":"Adenine nucleotides attenuate murine T cell activation induced by concanavalin A or T cell receptor stimulation","volume":"8","author":"Shinohara","year":"2018","journal-title":"Front Pharmacol"},{"key":"key20200713234149_b14-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20200713234149_b15-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"K\u00fcsters","year":"1996","journal-title":"Gastroenterology"},{"key":"key20200713234149_b16-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.02.029","article-title":"Use of TNF\u03b1 antagonists in refractory AIH: Revealing the unforeseen","volume":"59","author":"Saitis","year":"2013","journal-title":"J Hepatol"},{"key":"key20200713234149_b17-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"key":"key20200713234149_b18-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2013.05.001","article-title":"Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6","volume":"44","author":"Hintermann","year":"2013","journal-title":"J Autoimmun"},{"key":"key20200713234149_b19-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","article-title":"The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development","volume":"78","author":"Hardtke-Wolenski","year":"2017","journal-title":"J Autoimmun"},{"key":"key20200713234149_b20-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"key20200713234149_b21-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000282068","article-title":"Cytochrome P450 2D6 as a model antigen","volume":"28","author":"Christen","year":"2010","journal-title":"Dig Dis"},{"key":"key20200713234149_b22-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","article-title":"Janus kinases in immune cell signaling","volume":"228","author":"Ghoreschi","year":"2009","journal-title":"Immunol Rev"},{"key":"key20200713234149_b23-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"key20200713234149_b24-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/leu.2015.218","article-title":"Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function","volume":"30","author":"Perner","year":"2016","journal-title":"Leukemia"},{"key":"key20200713234149_b25-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"key20200713234149_b26-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","article-title":"Tofacitinib: A review in rheumatoid arthritis","volume":"77","author":"Dhillon","year":"2017","journal-title":"Drugs"},{"key":"key20200713234149_b27-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","article-title":"The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis","volume":"74","author":"Boyle","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key20200713234149_b28-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or Adalimumab versus placebo for psoriatic arthritis","volume":"377","author":"Mease","year":"2017","journal-title":"N Engl J Med"},{"key":"key20200713234149_b29-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2017.07.027","article-title":"Tofacitinib is the right OCTAVE for ulcerative colitis","volume":"153","author":"Pouillon","year":"2017","journal-title":"Gastroenterology"},{"key":"key20200713234149_b30-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaad.2017.03.024","article-title":"Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata","volume":"77","author":"Bayart","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key20200713234149_b31-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J Immunol"},{"key":"key20200713234149_b32-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"928790","DOI":"10.1155\/2013\/928790","article-title":"Improvement of hydrodynamics-based gene transfer of nonviral DNA targeted to murine hepatocytes","volume":"2013","author":"Nakamura","year":"2013","journal-title":"Biomed Res Int"},{"key":"key20200713234149_b33-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/rheumatology\/kex258","article-title":"Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model","volume":"57","author":"Vidal","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"key20200713234149_b34-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.intimp.2019.01.037","article-title":"IL-37 suppresses the sustained hepatic IFN-\u03b3\/TNF-\u03b1 production and T cell-dependent liver injury","volume":"69","author":"Feng","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"key20200713234149_b35-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molimm.2018.05.005","article-title":"TLR2\/4 ligand-amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6\/IL-12\/IL-4\/IL-25 expression","volume":"99","author":"Chi","year":"2018","journal-title":"Mol Immunol"},{"key":"key20200713234149_b36-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713234149_b37-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41374-018-0134-4","article-title":"Overexpression of KLF14 protects against immune-mediated hepatic injury in mice","volume":"99","author":"Chen","year":"2019","journal-title":"Lab Invest"},{"key":"key20200713234149_b38-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1159\/000489074","article-title":"Comparison of concanavalin a-induced murine autoimmune hepatitis models","volume":"46","author":"Ye","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"key20200713234149_b39-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jvh.12152","article-title":"Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)\/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B","volume":"21","author":"Li","year":"2014","journal-title":"J viral hepatitis"},{"key":"key20200713234149_b40-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"e39307","DOI":"10.1371\/journal.pone.0039307","article-title":"Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"key20200713234149_b41-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/jgh.12952","article-title":"Autoimmune hepatitis: East meets west","volume":"30","author":"Yang","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713234149_b42-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaut.2016.07.005","article-title":"Cutting edge issues in autoimmune hepatitis","volume":"75","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"key20200713234149_b43-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1007\/s10620-009-1122-8","article-title":"Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis","volume":"55","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key20200713234149_b44-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41374-018-0043-6","article-title":"SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition","volume":"98","author":"Lopez-Sanz","year":"2018","journal-title":"Lab Invest"},{"key":"key20200713234149_b45-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0140-6736(17)31618-5","article-title":"Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): A phase 3b\/4, double-blind, head-to-head, randomised controlled trial","volume":"390","author":"Fleischmann","year":"2017","journal-title":"Lancet"},{"key":"key20200713234149_b46-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s40273-018-0639-0","article-title":"Tofacitinib for treating rheumatoid arthritis after the failure of disease-modifying anti-rheumatic drugs: An evidence review group perspective of a NICE single technology appraisal","volume":"36","author":"Uttley","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"key20200713234149_b47-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/apt.14669","article-title":"Review article: Novel oral-targeted therapies in inflammatory bowel disease","volume":"47","author":"White","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"key20200713234149_b48-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/1203475418760512","article-title":"A case report highlighting the effective treatment of alopecia universalis with tofacitinib in an adolescent and adult patient","volume":"22","author":"Patel","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"key20200713234149_b49-mmr-20-06-4883","first-page":"774","article-title":"Preventive therapies for chronic migraine","volume":"378","author":"Silberstein","year":"2018","journal-title":"N Engl J Med"},{"key":"key20200713234149_b50-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"key20200713234149_b51-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.4049\/jimmunol.0900547","article-title":"SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis","volume":"183","author":"Nakaya","year":"2009","journal-title":"J Immunol"},{"key":"key20200713234149_b52-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.26027","article-title":"Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice","volume":"57","author":"Kato","year":"2013","journal-title":"Hepatology"},{"key":"key20200713234149_b53-mmr-20-06-4883","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clim.2012.10.008","article-title":"TNF-\u03b1 is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression","volume":"146","author":"Iwamoto","year":"2013","journal-title":"Clin Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:37:31Z","timestamp":1594687051000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10750","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]}}}